BP31510 Ubidecarenone nanosuspension (USP)

Ubidecarenone · BPGbio

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for BP31510 Ubidecarenone nanosuspension (USP), covering 2025-02-19 to 2025-02-19. Get the full timeline:

Most recent: Clinical Trial Update: BP31510 (Ubidecarenone,USP) Nanosuspension for Intravenous Injection to Patients With Solid Tumors [Phase 1]